Trials / Completed
CompletedNCT02725476
Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)
An Open-label, Single-arm, Pilot Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Xencor, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Phase 2 study is to investigate the effect of XmAb5871 on IgG4-Related Disease (RD) activity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | XmAb5871 |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2016-04-01
- Last updated
- 2018-12-07
- Results posted
- 2018-12-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02725476. Inclusion in this directory is not an endorsement.